Asia Transactions
Bridging Global Innovation Through Local Connectivity in China
Our China Capabilities
What We Do
- Identify high-value public and private Chinese biotechs with differentiated assets, preferably clinical stage
- Support clients on sell-side global licensing and M&A transactions designed for the Chinese market
- Co-found US-based NewCos based on Chinese assets in an arms-length process to maximize value for all stakeholders, the originator, NewCo co-founders, and new investors. We focus our NewCos on assets that have pharma strategic interest yet might be slightly early for a global strategic transaction
What Sets Us Apart
- Embedded Local Team: Professionals with extensive China deal experience, speak Mandarin, and broad relationships throughout the ecosystem yet executed by our US deal team
- Unique Partner Access: Deep relationships with global pharma, biotech, and investors to bring differentiated Chinese assets to a global audience
- Scientific Rigor & Market Intelligence: Since our entire deal team has a scientific rigor and/or material experience working in industry enables effective asset
positioning and selling to relevant buyers - Full Transaction Execution: From initial evaluation to negotiation and closing across licensing, M&A, and NewCo creation
Bridging Global Innovation Through Local Insight in Japan
Locust Walk helps biopharma companies navigate complex Asia markets, connecting global innovation with local expertise. Our on-the-ground team in Japan combines deep market knowledge, regulatory insight, and senior industry relationships to accelerate strategic transactions.
Japan Capabilities
What We Do
- Structure licensing, M&A, and strategic collaborations for global pharma and biotech doing deals with Japanese companies
- Supporting Japanese pharma and biotech execute global sell-side or buy-side transactions to access external innovation
- Navigate cultural nuances to ensure seamless execution and alignment
What Sets Us Apart
- Local Expertise: Japanese-speaking team embedded in Tokyo the past 12 years
- Trusted Relationships: Connections with the C-suite of all leading Japanese pharma players
- End-to-End Execution: Managing process from deal launch to closing
Our China Capabilities
Locust Walk’s China team provides end-to-end support for companies seeking to source innovation from or expand partnerships into China.
Holistic Market Intelligence
We go beyond public data—combining local sentiment, ecosystem insights, and informal indicators to assess opportunities.
Embedded Local Team
Our China team operates in-market, backed by global processes to ensure deal quality and consistency.
Unique Dealflow Expertise
We navigate six distinct company types and understand the regulatory, policy, and access dynamics others often miss.
Proven Deal Process
Our Japan Capabilities
What Sets Us Apart:
Deep-Rooted Relationships
Local Insight, Global Execution
Strategic Navigation of the Japanese Landscape
Track Record Across Deal Types
Meet Our Asia Leadership
Start the Conversation
Looking to explore a transaction in China or Japan? Our team is ready to help.
To schedule a meeting, contact us at asia@locustwalk.com.